Cari-Anne Quinn
Cancer care in Wales is advancing with the ambition to improve survival rates, which currently fall behind those of many other countries, including ones of similar size and wealth.
Driving innovation to frontline services is essential, enabled by building enduring partnerships across sectors to rapidly translate research into practice and co-develop solutions. We’re investing in strengthening our health and care system to become an early adopter of transformative innovation.
Cancer care priorities
Wales’ Cancer Improvement Plan and National Cancer Research Strategy identify key priorities focused on prevention, earlier detection and personalised cancer care through genomics. Research themes include precision and mechanistic oncology, immuno-oncology and data-driven predictive analytics.
Investment in key infrastructure includes the All-Wales Medical Genomics Service, Wales Cancer Bank, the Wales Cancer Research Centre and data infrastructure including the SAIL Databank and Artificial Intelligence Commission.
We’re playing a critical role in supporting the
Welsh Government Tackling Cancer initiative.
Lung cancer remains the leading cause of cancer deaths; skin cancer cases are rising; and urological, breast, colorectal and gynaecological cancers present significant burdens.
Accelerating cancer innovation
New service models and technologies are being rapidly co-developed, such as the QuicDNA programme, which offers liquid biopsies for early lung cancer detection. This programme is currently being trialled with a consortium of international partners.
We’re playing a critical role in supporting the Welsh Government Tackling Cancer initiative. Fostering collaboration between industry, healthcare, academia and charities to accelerate the deployment of innovative cancer care solutions. Wales is seeking to co-develop and adopt at pace. Join us in the fight against cancer.
Pitch your cancer innovations here: lshubwales.com/innovation-enquiry-form.
